Tamoxifen, raloxifene cut breast cancer risk - latimes.com
Links shared publicly online about this topic.
- 1,212total visits
Tamoxifen, raloxifene cut breast cancer risk - latimes.com
View full resource at latimes.com
Tags: Cancer, Breast Cancer, Osteoporosis Medication, Women's Health, Evista
Most Recently Shared on April 26, 2010 at 7:17 pm By:
#Tamoxifen & raloxifene cut #breast #cancer risk in half. Tamoxifen better than raloxifene. http://bit.ly/9eB1tn #AACR10
Susan G. Komen for the Cure | Understanding Breast Cancer | Risk Factors and Prevention | Risk-Lowering Drugs
ww5.komen.org — “A great deal of research is being done on drugs that can lower the risk of breast cancer in women at higher risk. Tamoxifen and raloxifene are the most well-studied of these drugs. For a summary of re” View full resource at ww5.komen.org
Most Recently Shared on November 18, 2011 at 9:50 pm By:
Komen for the Cure Health Organization
Learn more about risk-lowering drugs here: http://t.co/q4UOKbWH #breastcancer
As reported earlier... | Facebook
facebook.com — “Columbia University Department of Surgery wrote: As reported earlier this year, the drug... Join Facebook to connect with Columbia University Department of Surgery and others you may know.” View full resource at facebook.com
Most Recently Shared on October 22, 2011 at 11:00 am By:
Is exemestane effective in preventing all forms of breast cancer? http://t.co/Kv8YOItU
Tamoxifen Gives 15-Year Breast Cancer Protection - QualityPoint Technologies
qualitypointtech.net — “Five-year tamoxifen treatment -- with or without chemotherapy -- cuts a woman's 15-year risk of breast-cancer death by about a third, long-term data show. (Source: WebMD Health)MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.” View full resource at qualitypointtech.net
Most Recently Shared on July 29, 2011 at 4:00 am By:
Tamoxifen Gives 15-Year Breast Cancer Protection: Five-year tamoxifen treatment -- with or without chemotherapy --... http://bit.ly/plbvUx
Oncology Article | Breast Neoplasms Chemoprevention Tamoxifen Raloxifene
mdlinx.com — “Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older” View full resource at mdlinx.com
Most Recently Shared on May 5, 2011 at 6:54 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 5... http://bit.ly/mE6Vt5 #oncology
NCI Cancer Bulletin for May 3, 2011 - National Cancer Institute
cancer.gov — “NCI Cancer Bulletin for May 3, 2011 - National Cancer Institute” View full resource at cancer.gov
Most Recently Shared on May 4, 2011 at 12:09 pm By:
NCI Cancer Bulletin Health News
Tool weighs benefits, risks of raloxifene or tamoxifen to prevent breast cancer http://1.usa.gov/kesVI1
Anti-estrogen medication 'cuts risk of dying from lung cancer' - World News, 131304
newkerala.com — “Anti-estrogen medication 'cuts risk of dying from lung cancer' - Washington, Jan 24 : Tamoxifen, an anti-estrogen breast cancer medication, may reduce an individual's risk of death from lung cancer, says a new study.” View full resource at newkerala.com
Most Recently Shared on January 24, 2011 at 11:51 am By:
Anti-estrogen medication 'cuts risk of dying from lung cancer': Washington, Jan 24 : Tamoxifen, an anti-estrogen... http://bit.ly/gs8IHe
SERMs: Underused and under the radar | HemOncToday
hemonctoday.com — “The selective estrogen receptor modulators tamoxifen and raloxifene have been shown to reduce the risk for breast cancer in women at high risk b” View full resource at hemonctoday.com
Most Recently Shared on October 6, 2010 at 1:51 am By:
Wafik El-Deiry MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
SERMs: Underused and under the radar | HemOncToday: http://bit.ly/b7piQT
The puzzle of why more women don't take preventive drugs for breast cancer - QualityPoint Technologies
qualitypointtech.net — “For women at higher risk of developing breast cancer, two well-established drugs, tamoxifen and raloxifene, can do what statins do for heart attacks and strokes: drive down the odds. But these two drugs are virtually invisible on the U.S. pharmaceutical landscape.The millions of Americans who take a pill each day to drive down their cholesterol or blood pressure do not generally think of themselves as” View full resource at qualitypointtech.net
Most Recently Shared on October 2, 2010 at 8:36 pm By:
The puzzle of why more women don't take preventive drugs for breast cancer: For women at higher risk of developin... http://bit.ly/bUYwel
Tamoxifen, raloxifene and tibolone decrease risk of invasive breast cancer in healthy women but increase risk of thromboembolism (tamoxifen, raloxifene), endometrial cancer (tamoxifen) or stroke (tibolone) -- Vogel 15 (4): 122 -- Evidence-Based Medicine
ebm.bmj.com — “Vogel, Victor G” View full resource at ebm.bmj.com
Most Recently Shared on August 4, 2010 at 12:23 pm By:
Tamoxifen, raloxifene and tibolone decrease risk of invasive breast cancer in healthy women but increase risk of t... http://bit.ly/aRxUbY
Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis -- Ropka et al., 10.1200/JCO.2009.27.8077 -- Journal of Clinical Oncology
jco.ascopubs.org — “Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis -- Ropka et al., 10.1200/JCO.2009.27.8077 -- Journal of Clinical Oncology” View full resource at jco.ascopubs.org
Most Recently Shared on May 11, 2010 at 2:44 pm By:
NCI Cancer Bulletin Health News
RT @EdwardWinstead More studies needed of why women @ inc breast cancer risk do/don't take tamoxifen or raloxifene http://bit.ly/dlpPr7
Tamoxifen, Evista Prevent Breast Cancer
webmd.com — “Updated results from a large breast cancer prevention trial confirm that both the old standby tamoxifen and the osteoporosis drug Evista can substantially cut the risk of developing breast cancer in high-risk postmenopausal women.” View full resource at webmd.com
Most Recently Shared on April 20, 2010 at 8:15 pm By:
Tamoxifen, Evista Prevent Breast Cancer: Updated results from a large breast cancer prevention trial confirm that ... http://bit.ly/csYNyi
Tamoxifen, raloxifene cut breast cancer risk in half
links.assetize.com — “Assetize is a targeted advertising network for Twitter.” View full resource at links.assetize.com
Most Recently Shared on April 20, 2010 at 5:12 pm By:
Health,Fitness,Diet Health Business
Tamoxifen, raloxifene cut breast cancer risk in half http://bit.ly/9iKWdz
Tamoxifen, raloxifene cut breast cancer risk in half - Los Angeles Times
articles.latimes.com — “Two drugs taken by women at high risk for breast cancer — tamoxifen and raloxifene — both reduce the risk of the disease by about 50% in high-risk post-menopausal women while they are” View full resource at articles.latimes.com
Most Recently Shared on April 20, 2010 at 7:17 am By:
Tamoxifen, raloxifene cut breast cancer risk in half: Women at high risk can take either drug as preventive therap... http://lat.ms/cg5eXl
Study Finds Tamoxifen More Effective Than Lilly's Evista in Breast-Cancer Prevention Many Years After Treatment - WSJ.com
online.wsj.com — “Both drugs cut high-risk women's risk of developing breast cancer, according to a study presented April 19 at the American Association for Cancer Research.” View full resource at online.wsj.com
Most Recently Shared on April 20, 2010 at 1:08 am By:
Older Drug Cuts Cancer Risk More http://on.wsj.com/clwmfv
Study Finds Tamoxifen More Effective Than Lilly's Evista in Breast-Cancer Prevention Many Years After Treatment - WSJ.com
online.wsj.com — “Both drugs cut high-risk women's risk of developing breast cancer, according to a study presented April 19 at the American Association for Cancer Research.” View full resource at online.wsj.com
Most Recently Shared on April 20, 2010 at 12:48 am By:
Men For A Cause (TM) Health Organization
Study Finds Tamoxifen More Effective Than Lilly's Evista in Breast-Cancer Prevention Many Years After Treatment-WSJ.com http://shar.es/mvAtp
Advertisement
